7 Developments in Primary Care This Month

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Both metformin and GLP-1 RAs have been studies for their neuroprotective effects; this study is the first head-to-head investigation and supports further research.

What is Driving Type 2 Diabetes in the US?

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Obesity & Type 2 Diabetes: An Expert Discussion

Type 2 diabetes and its high and rising rates in the US are the result of a perfect storm of converging systemic, behavioral, environmental, and economic factors.

New Guidelines Recommend Preconception Screening in Diabetes, Universal Testing for Primary Aldosteronism

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Obesity Redefined: 1 in 5 Adults Reclassified Under New EASO Criteria

ENDO 2025: The publications reflect growing consensus that integration of endocrine screening into standard clinical workflows is essential for early risk detection and long-term disease prevention.

GLP-1 RAs vs Metformin Significantly Reduce Risk of Dementia in Adults with Type 2 Diabetes

Individuals newly classified with obesity using the European framework were found to be overall sicker and at greater risk for mortality.

Related Content

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Both metformin and GLP-1 RAs have been studies for their neuroprotective effects; this study is the first head-to-head investigation and supports further research.

What is Driving Type 2 Diabetes in the US?

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Obesity & Type 2 Diabetes: An Expert Discussion

Type 2 diabetes and its high and rising rates in the US are the result of a perfect storm of converging systemic, behavioral, environmental, and economic factors.

New Guidelines Recommend Preconception Screening in Diabetes, Universal Testing for Primary Aldosteronism

In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.

Obesity Redefined: 1 in 5 Adults Reclassified Under New EASO Criteria

ENDO 2025: The publications reflect growing consensus that integration of endocrine screening into standard clinical workflows is essential for early risk detection and long-term disease prevention.